A treatment pulled off the market 30 years ago has won Food and Drug Administration approval again as the only drug designated to treat morning sickness. That long-ago safety scare, prompted by hundreds of lawsuits claiming birth defects, proved to be a false alarm. Monday's decision means a new version of the pill once called Bendectin is set to return to U.S. pharmacies in June under a different name — Diclegis. An initial version of Bendectin began selling in 1956, and 33 million women around the world were estimated to have taken it before the lawsuits began. At the time, the F.D.A. continued to call the drug safe. But its maker, Merrell Dow, declared the litigation cost too high, and quit making Bendectin in 1983.
Anda sedang membaca artikel tentang
National Briefing | Washington: Morning Sickness Drug Returns
Dengan url
http://healtybodyguard.blogspot.com/2013/04/national-briefing-washington-morning.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
National Briefing | Washington: Morning Sickness Drug Returns
namun jangan lupa untuk meletakkan link
National Briefing | Washington: Morning Sickness Drug Returns
sebagai sumbernya
0 komentar:
Posting Komentar